ARVN Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$8.83

Capitalizzazione di Mercato

$753M

P/E (TTM)

-10.4

EPS (TTM)

$-1.14

Ricavi (TTM)

$263M

Rendimento div.

—

ROE

-15.5%

D/E Debito/Patrimonio

0.0

Intervallo 52 sett.

$6 – $15

ARVN Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $263M

2017-12-31 → 2025-12-31

EPS $-1.14

2019-12-31 → 2025-12-31

Flusso di cassa libero $-276M

2018-12-31 → 2025-12-31

Margini -30.8%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

ARVN

Mediana dei peer

P/E (TTM)

-10.4

8.2

P/S (TTM)

2.9

6.3

P/B

1.7

3.2

EV / EBITDA

-0.6

—

Price / FCF (Prezzo / FCF)

-2.7

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

ARVN

Mediana dei peer

Operating Margin (Margine Operativo)

-45.1%

—

Net Profit Margin (Margine di Profitto Netto)

-30.8%

13.6%

ROA

-8.9%

-17.1%

ROE

-15.5%

-15.8%

ROIC

-27.4%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

ARVN

Mediana dei peer

Debt / Equity (Debito / Patrimonio Netto)

0.0

0.1

Current Ratio (Rapporto corrente)

4.9

4.8

Quick Ratio

4.8

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

ARVN

Mediana dei peer

Revenue YoY (Ricavi YoY)

-0.30%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

26.0%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

58.9%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

ARVN

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-1.14

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

ARVN

Mediana dei peer

ARVN Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 26 analisti

Acquisto forte 6 23,1%
Compra 10 38,5%
Mantieni 9 34,6%
Vendi 1 3,8%
Vendita forte 0 0,0%

Target Price a 12 Mesi

16 analisti · 2026-05-20

Mediana $15.50

Ora $8.83

Basso $6.00

Alto $24.00

Target mediano $15.50 +75,5%

Target medio $15.00 +69,9%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.43%

Periodo	EPS Actual	EPS Stimato	Sorpresa
31 Marzo 2026	$-0.90	$-0.94	0.04%
31 Dicembre 2025	$-1.10	$-0.60	-0.50%
30 Settembre 2025	$-0.48	$-0.81	0.33%
30 Giugno 2025	$-0.84	$-1.02	0.18%
31 Marzo 2025	$1.14	$-0.97	2.1%

Confronto tra pari Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
ARVN	$753M	-10.4	-0.30%	-30.8%	-15.5%	—
SGP	—	—	—	—	50.0%	—
ANRO	$568M	-8.1	—	—	-46.1%	—
ACRS	$363M	-5.7	-58.2%	-829.6%	-55.3%	—
CRMD	$922M	5.7	617.0%	52.3%	52.1%	88.5%
ZVRA	$509M	6.6	350.9%	78.2%	61.2%	—
AQST	$788M	-8.3	-22.6%	-188.1%	157.7%	—
CTNM	—	-5.3	—	—	-27.7%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 16

Dati annuali Conto Economico per ARVN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$263M	$263M	$78M	$131M	$54M	$26M	$43M	$14M	$8M
R&D Expense	$285M	$348M	$380M	$315M	$180M	$108M	$67M	$45M	$29M
SG&A Expense	$96M	$165M	$100M	$80M	$62M	$38M	$27M	$13M	$4M
Operating Expenses	$381M	$514M	$480M	$395M	$242M	$147M	$94M	$58M	$32M
Operating Income	$-118M	$-250M	$-402M	$-263M	$-188M	$-121M	$-52M	$-44M	$-25M
Interest Expense	·	$0	$0	$0	$0	$100.0K	$100.0K	$57.4K	$50.4K
Interest Income	$38M	$55M	$39M	$12M	$2M	$4M	$5M	$2M	$201.4K
Other Non-op	$-400.0K	$-3M	$-1M	$200.0K	$2M	$2M	$1M	$102.7K	$554.2K
Pretax Income	$-80M	$-198M	$-364M	$-251M	$-184M	$-115M	·	·	·
Income Tax	$300.0K	$600.0K	$900.0K	$21M	$0	$0	$0	$0	$0
Net Income	$-81M	$-199M	$-367M	$-282M	$-191M	$-119M	$-70M	$-41M	$-24M
EPS (Basic)	$-1.14	$-2.77	$-6.62	$-5.31	$-3.82	$-3.02	$-2.13	·	·
EPS (Diluted)	$-1.14	$-2.77	$-6.62	$-5.31	$-3.82	$-3.02	$-2.13	·	·
Shares (Basic)	70,900,000	71,900,000	55,500,000	53,200,000	50,000,000	39,500,000	32,900,000	·	·
Shares (Diluted)	70,900,000	71,900,000	55,500,000	53,200,000	50,000,000	39,500,000	32,900,000	·	·
EBITDA	$-118M	$-250M	$-402M	$-263M	$-195M	$-125M	$-52M	$-44M	·

Stato Patrimoniale 26

Dati annuali Stato Patrimoniale per ARVN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$143M	$100M	$312M	$81M	$108M	$588M	$9M	$3M	$31M
Short-term Investments	$542M	$939M	$949M	$1.12B	$1.39B	$100M	$272M	$185M	$8M
Receivables	$1M	$6M	$0	$1M	$15M	$1M	·	$3M	$25M
Prepaid Expense	$9M	$14M	$6M	$21M	$20M	$6M	$4M	$3M	$316.9K
Current Assets	$701M	$1.07B	$1.28B	$1.24B	$1.55B	$703M	$291M	$196M	$66M
PP&E (Net)	$5M	$7M	$12M	$13M	$13M	$12M	$8M	$4M	$1M
PP&E (Gross)	$33M	$33M	$33M	$30M	$23M	$18M	$12M	$5M	$2M
Accum. Depreciation	$28M	$26M	$21M	$17M	$11M	$6M	$3M	$2M	$1M
Other Non-current Assets	·	·	·	·	·	$28.8K	$26.8K	$20.8K	·
Total Assets	$718M	$1.09B	$1.30B	$1.27B	$1.58B	$717M	$302M	$199M	$67M
Accounts Payable	$24M	$13M	$18M	$6M	$31M	$7M	$5M	$3M	$596.5K
Accrued Liabilities	·	·	·	·	$23M	$19M	$8M	$4M	$4M
Current Liabilities	$142M	$230M	$257M	$295M	$262M	$49M	$33M	$23M	$18M
Capital Leases	$7M	$7M	$500.0K	$3M	$3M	$1M	$2M	·	·
Other Non-current Liabilities	·	·	·	·	·	·	·	$150.0K	·
Total Liabilities	$284M	$530M	$645M	$704M	$800M	$75M	$75M	$63M	$67M
Long-term Debt	$600.0K	$800.0K	$1M	$1M	$1M	$2M	$2M	$2M	$310.4K
Total Debt	$600.0K	$800.0K	$1M	$1M	$1M	$2M	$2M	$2M	·
Common Stock	$100.0K	$100.0K	$100.0K	$100.0K	$0	$0	$38.5K	$31.2K	·
Paid-in Capital	$2.14B	$2.09B	$2.00B	$1.55B	$1.47B	$1.13B	$599M	$439M	·
Retained Earnings	$-1.61B	$-1.53B	$-1.33B	$-965M	$-683M	$-492M	$-373M	$-302M	$-62M
Treasury Stock	$92M	$0	·	·	·	·	·	·	·
AOCI	$1M	$1M	$-3M	$-19M	$-5M	$600.0K	$107.6K	$-217.7K	$-9.8K
Stockholders' Equity	$434M	$562M	$660M	$565M	$782M	$642M	$227M	$137M	$-61M
Liabilities + Equity	$718M	$1.09B	$1.30B	$1.27B	$1.58B	$717M	$302M	$199M	$67M
Shares Outstanding	63,500,000	68,800,000	68,000,000	53,200,000	53,000,000	48,500,000	38,500,000	31,200,000	·

Flusso di cassa 17

Dati annuali Flusso di cassa per ARVN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$3M	$5M	$5M	$6M	$5M	$3M	$2M	$706.0K	$347.4K
Stock-based Comp	$44M	$88M	$72M	$76M	$57M	$30M	$20M	$12M	$245.0K
Deferred Tax	$0	$0	$0	$0	$0	$0	·	·	·
Restructuring	$4M	$0	$0	·	·	·	·	·	·
Operating Cash Flow	$-274M	$-259M	$-348M	$-274M	$559M	$-90M	$-41M	$-16M	$5M
CapEx	$2M	$2M	$3M	$7M	$5M	$6M	$6M	$3M	$1M
Investing Cash Flow	$408M	$35M	$204M	$243M	$-1.31B	$164M	$-93M	$-180M	$21M
Debt Issued	·	·	·	·	·	$0	$0	$2M	$0
Net Debt Issued	$-200.0K	$-400.0K	·	·	$0	$0	$-169.6K	$2M	·
Stock Issued	·	·	·	·	·	·	$138M	$115M	$0
Stock Repurchased	$92M	$0	$0	·	·	·	·	·	·
Net Stock Activity	$-92M	·	·	·	·	·	$138M	$115M	·
Financing Cash Flow	$-91M	$8M	$375M	$5M	$279M	$505M	$140M	$168M	$-161.4K
Net Change in Cash	$42M	$-217M	$230M	$-26M	$-476M	$579M	$6M	$-28M	$26M
Taxes Paid	$-400.0K	$2M	$11M	$11M	$0	$0	·	·	·
Free Cash Flow	$-276M	$-261M	$-351M	$-280M	$555M	$-96M	$-47M	$-19M	·
Levered FCF	·	$-261M	$-351M	·	·	·	·	·	·

Redditività 7

Dati annuali Redditività per ARVN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Operating Margin	-45.1%	-95.0%	-511.5%	-200.3%	-418.2%	-572.7%	-119.9%	-305.8%	·
Net Margin	-30.8%	-75.5%	-467.9%	-215.0%	-409.0%	-547.3%	-163.6%	-289.6%	·
Pretax Margin	-30.6%	-75.3%	-463.6%	-191.0%	·	·	·	·	·
EBITDA Margin	-45.1%	-95.0%	-511.5%	-200.3%	-418.2%	-572.7%	-119.9%	-305.8%	·
ROA	-8.9%	-16.6%	-28.5%	-19.8%	-16.6%	-23.4%	-28.1%	-31.2%	·
ROE	-15.5%	-34.7%	-65.8%	-47.6%	-23.9%	-28.2%	-39.0%	58.4%	·
ROIC	-27.4%	-44.6%	-60.9%	-50.4%	·	·	·	·	·

Liquidità e Solvibilità 5

Dati annuali Liquidità e Solvibilità per ARVN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	4.9	4.6	5.0	4.2	5.9	14.3	8.9	8.5	·
Quick Ratio	4.8	4.5	4.9	4.1	5.8	14.0	8.6	8.3	·
Debt / Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	·
LT Debt / Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	·
Interest Coverage	·	·	·	·	-1953.0	-1920.9	-602.1	-762.6	·

Efficienza 2

Dati annuali Efficienza per ARVN
Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover		0.3	0.2	0.1	0.1	0.0	0.0	0.2	0.1	·
Receivables Turnover		78.4	40.5	10.0	131.4	5.5	11.5	·	1.0	·

Per Azione 5

Dati annuali Per Azione per ARVN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$6.83	$8.16	$9.71	$10.62	$14.75	$13.25	$5.89	$4.38	·
Revenue / Share	$3.70	$3.66	$1.41	$2.47	$0.93	·	·	·	·
Cash Flow / Share	$-3.86	$-3.61	$-6.27	$-5.14	$11.19	·	·	·	·
Cash / Share	$2.25	$1.46	$4.58	$1.53	$2.04	$12.14	$0.24	$0.10	·
EPS (TTM)	$-1.14	$-2.77	$-6.62	$-5.31	$-3.82	$-3.02	$-2.13	·	·

Tassi di Crescita 3

Dati annuali Tassi di Crescita per ARVN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-0.30%	235.5%	-40.3%	145.2%	106.9%	·	·	·	·
Revenue CAGR 3Y	26.0%	70.0%	44.7%	·	·	·	·	·	·
Revenue CAGR 5Y	58.9%	·	·	·	·	·	·	·	·

Valutazione (TTM) 14

Dati annuali Valutazione (TTM) per ARVN
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$263M	$263M	$78M	$131M	$54M	$26M	$43M	$14M	·
Net Income TTM	$-81M	$-199M	$-367M	$-282M	$-191M	$-119M	$-70M	$-41M	·
Market Cap	$753M	$1.32B	$2.80B	$1.82B	$4.35B	$4.12B	$1.58B	$401M	·
Enterprise Value	$68M	$280M	$1.54B	$616M	$2.85B	$3.43B	$1.30B	$216M	·
P/E	-10.4	-6.9	-6.2	-6.4	-21.5	-28.1	-19.3	·	·
P/S	2.9	5.0	35.7	13.9	81.2	158.9	36.8	28.0	·
P/B	1.7	2.3	4.2	3.2	5.6	6.4	7.0	2.9	·
P / Tangible Book	1.7	2.3	4.2	3.2	5.6	6.4	·	·	·
P / Cash Flow	-2.8	-5.1	-8.0	-6.7	7.8	-45.8	-38.9	-24.9	·
P / FCF	-2.7	-5.1	-8.0	-6.5	7.8	-42.8	-33.7	-21.2	·
EV / EBITDA	-0.6	-1.1	-3.8	-2.3	-14.6	-27.5	-25.3	-4.9	·
EV / FCF	-0.2	-1.1	-4.4	-2.2	5.1	-35.6	-27.8	-11.4	·
EV / Revenue	0.3	1.1	19.6	4.7	53.2	132.4	30.3	15.1	·
Earnings Yield	-9.6%	-14.4%	-16.1%	-15.5%	-4.7%	-3.6%	-5.2%	·	·

Conto Economico 16

Dati trimestrali Conto Economico per ARVN
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$16M	$10M	$42M	$22M	$189M	$59M	$102M	$76M	$25M	$-43M	$35M	$54M	$32M	$38M	$33M	$34M
R&D Expense	$60M	$61M	$65M	$69M	$91M	$83M	$87M	$94M	$84M	$95M	$86M	$103M	$95M	$98M	$78M	$75M
SG&A Expense	$19M	$23M	$21M	$25M	$27M	$34M	$76M	$31M	$24M	$27M	$23M	$26M	$25M	$15M	$20M	$24M
Operating Expenses	$79M	$84M	$86M	$94M	$117M	$117M	$163M	$125M	$109M	$122M	$108M	$129M	$120M	$113M	$98M	$100M
Operating Income	$-64M	$-75M	$-44M	$-72M	$71M	$-58M	$-60M	$-48M	$-83M	$-165M	$-74M	$-75M	$-88M	$-75M	$-64M	$-66M
Interest Expense	·	·	·	$0	$0	·	$0	$0	$0	·	$0	$0	$0	$0	$0	$0
Interest Income	$6M	$7M	$9M	$10M	$12M	$13M	$14M	$14M	$14M	$12M	$10M	$9M	$8M	$6M	$3M	$2M
Other Non-op	$-100.0K	$-12M	$0	$-300.0K	$0	$-14M	$-3M	$-100.0K	$14M	$-100.0K	$0	$0	$-1M	$600.0K	$-200.0K	$-100.0K
Pretax Income	$-58M	$-67M	$-35M	$-62M	$83M	$-45M	$-49M	$-35M	$-69M	$-153M	$-64M	$-66M	$-81M	$-69M	$-61M	$-64M
Income Tax	$100.0K	$100.0K	$300.0K	$-300.0K	$200.0K	$-300.0K	$600.0K	$200.0K	$100.0K	$2M	$0	$-300.0K	$-400.0K	$11M	$2M	$3M
Net Income	$-58M	$-67M	$-35M	$-61M	$83M	$-45M	$-49M	$-35M	$-69M	$-155M	$-64M	$-67M	$-82M	$-83M	$-66M	$-70M
EPS (Basic)	$-0.90	$-0.96	$-0.48	$-0.84	$1.14	$-0.63	$-0.68	$-0.49	$-0.97	$-2.65	$-1.18	$-1.25	$-1.54	$-1.55	$-1.24	$-1.32
EPS (Diluted)	$-0.90	$-0.96	$-0.48	$-0.84	$1.14	$-0.63	$-0.68	$-0.49	$-0.97	$-2.65	$-1.18	$-1.25	$-1.54	$-1.55	$-1.24	$-1.32
Shares (Basic)	64,000,000	-147,800,000	73,200,000	73,000,000	72,500,000	-143,800,000	72,100,000	71,900,000	71,700,000	-105,300,000	54,100,000	53,400,000	53,300,000	-106,200,000	53,200,000	53,200,000
Shares (Diluted)	64,000,000	-148,000,000	73,200,000	73,000,000	72,700,000	-143,800,000	72,100,000	71,900,000	71,700,000	-105,300,000	54,100,000	53,400,000	53,300,000	-106,200,000	53,200,000	53,200,000
EBITDA	$-64M	·	$-44M	$-72M	$71M	·	$-60M	$-48M	$-83M	·	$-74M	$-75M	$-88M	·	$-67M	$-68M

Stato Patrimoniale 23

Dati trimestrali Stato Patrimoniale per ARVN
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$87M	$143M	$102M	$115M	$81M	$100M	$85M	$155M	$88M	$312M	$114M	$91M	$130M	$81M	$133M	$93M
Short-term Investments	$528M	$542M	$686M	$746M	$873M	$939M	$1.04B	$1.07B	$1.08B	·	$885M	$948M	$993M	·	$1.14B	$1.25B
Receivables	$2M	$1M	$20M	$500.0K	$400.0K	$6M	$7M	$2M	$0	$0	$16M	$100.0K	$0	$1M	$1M	$1M
Prepaid Expense	$9M	$9M	$12M	$17M	$17M	$14M	$13M	$12M	$8M	·	$8M	$8M	$14M	·	$22M	$21M
Current Assets	$631M	$701M	$826M	$890M	$980M	$1.07B	$1.15B	$1.26B	$1.19B	·	$1.03B	$1.06B	$1.15B	·	$1.30B	$1.38B
PP&E (Net)	$6M	$5M	$5M	$6M	$7M	$7M	$7M	$10M	$10M	·	$13M	$13M	$13M	·	$14M	$14M
PP&E (Gross)	$34M	$33M	$33M	$33M	$33M	$33M	$31M	$33M	$33M	·	$33M	$32M	$31M	·	$29M	$27M
Accum. Depreciation	$28M	$28M	$28M	$27M	$26M	$26M	$24M	$23M	$22M	·	$20M	$19M	$18M	·	$15M	$14M
Total Assets	$648M	$718M	$844M	$909M	$1.00B	$1.09B	$1.17B	$1.28B	$1.21B	·	$1.06B	$1.08B	$1.18B	·	$1.33B	$1.41B
Accounts Payable	$31M	$24M	$18M	$17M	$26M	$13M	$18M	$23M	$18M	·	$34M	$7M	$12M	·	$8M	$12M
Current Liabilities	$116M	$142M	$145M	$158M	$214M	$230M	$276M	$347M	$241M	·	$317M	$307M	$283M	·	$245M	$238M
Capital Leases	$6M	$7M	$7M	$8M	$8M	$7M	$100.0K	$200.0K	$400.0K	·	$1M	$2M	$2M	·	$3M	$4M
Total Liabilities	$261M	$284M	$280M	$300M	$341M	$530M	$581M	$679M	$603M	·	$601M	$620M	$665M	·	$713M	$736M
Long-term Debt	$500.0K	$600.0K	$600.0K	$700.0K	$700.0K	$800.0K	$800.0K	$900.0K	$900.0K	·	$1M	$1M	$1M	·	$1M	$1M
Total Debt	$500.0K	·	$600.0K	$700.0K	$700.0K	·	$800.0K	$900.0K	$900.0K	·	$1M	$1M	$1M	·	$1M	$1M
Common Stock	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	·	$100.0K	$100.0K	$100.0K	·	$100.0K	$100.0K
Paid-in Capital	$2.15B	$2.14B	$2.13B	$2.12B	$2.11B	$2.09B	$2.07B	$2.04B	$2.02B	·	$1.64B	$1.59B	$1.57B	·	$1.53B	$1.51B
Retained Earnings	$-1.67B	$-1.61B	$-1.54B	$-1.51B	$-1.45B	$-1.53B	$-1.49B	$-1.44B	$-1.40B	·	$-1.18B	$-1.11B	$-1.05B	·	$-882M	$-816M
Treasury Stock	$92M	$92M	$20M	·	·	$0	·	·	·	·	·	·	·	·	·	·
AOCI	$-400.0K	$1M	$1M	$1M	$2M	$1M	$4M	$-4M	$-4M	·	$-9M	$-12M	$-13M	·	$-25M	$-22M
Stockholders' Equity	$387M	$434M	$564M	$609M	$660M	$562M	$586M	$600M	$610M	$660M	$457M	$464M	$511M	$565M	$622M	$671M
Liabilities + Equity	$648M	$718M	$844M	$909M	$1.00B	$1.09B	$1.17B	$1.28B	$1.21B	·	$1.06B	$1.08B	$1.18B	·	$1.33B	$1.41B
Shares Outstanding	64,500,000	63,500,000	70,800,000	73,200,000	73,000,000	68,800,000	68,700,000	68,600,000	68,300,000	68,000,000	55,000,000	53,400,000	53,400,000	53,200,000	53,200,000	53,200,000

Flusso di cassa 13

Dati trimestrali Flusso di cassa per ARVN
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$700.0K	$700.0K	$800.0K	$800.0K	$700.0K	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$2M	$2M	$2M
Stock-based Comp	$12M	$8M	$10M	$10M	$15M	$23M	$25M	$22M	$19M	$17M	$17M	$18M	$20M	$20M	$19M	$20M
Restructuring	$1M	$3M	$-200.0K	$1M	·	·	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-69M	$-30M	$-59M	$-95M	$-89M	$-84M	$-128M	$50M	$-98M	$-83M	$-85M	$-89M	$-91M	$-71M	$-67M	$-79M
CapEx	$1M	$200.0K	$100.0K	$1M	$400.0K	$300.0K	$700.0K	$700.0K	$100.0K	$100.0K	$1M	$600.0K	$1M	$1M	$2M	$1M
Investing Cash Flow	$14M	$146M	$64M	$129M	$70M	$99M	$50M	$13M	$-128M	$-54M	$70M	$49M	$139M	$19M	$106M	$109M
Net Debt Issued	$-100.0K	·	·	·	$-100.0K	·	·	·	$-200.0K	·	·	·	·	·	·	·
Stock Repurchased	·	$74M	·	·	·	$0	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$-100.0K	$-74M	$-18M	$500.0K	$-100.0K	$500.0K	$2M	$3M	$2M	$335M	$38M	$500.0K	$2M	$500.0K	$1M	$500.0K
Net Change in Cash	$-56M	$41M	$-13M	$34M	$-20M	$15M	$-75M	$67M	$-224M	$198M	$23M	$-40M	$49M	$-51M	$40M	$31M
Taxes Paid	·	$-700.0K	$300.0K	$0	$0	$700.0K	$100.0K	$300.0K	$1M	$2M	$100.0K	$9M	$0	$3M	$8M	·
Free Cash Flow	$-70M	·	·	·	$-89M	·	·	·	$-98M	·	·	·	$-92M	·	·	·
Levered FCF	·	·	·	·	$-89M	·	·	·	$-98M	·	·	·	$-92M	·	·	·

Redditività 7

Dati trimestrali Redditività per ARVN
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	-409.0%	·	-104.5%	-319.2%	37.8%	·	-58.9%	-63.4%	-329.2%	·	-213.6%	-136.9%	-269.9%	·	-221.8%	-218.2%
Net Margin	-369.2%	·	-83.8%	-273.2%	43.9%	·	-48.0%	-46.0%	-274.3%	·	-185.0%	-122.2%	-252.0%	·	-218.5%	-223.6%
Pretax Margin	-368.6%	·	-83.0%	-274.5%	44.0%	·	-47.5%	-45.8%	-273.9%	·	-184.7%	-120.4%	-249.8%	·	·	·
EBITDA Margin	-409.0%	·	-104.5%	-319.2%	37.8%	·	-58.9%	-63.4%	-329.2%	·	-213.6%	-136.9%	-269.9%	·	-221.8%	-218.2%
ROA	-7.0%	·	-3.5%	-5.6%	7.5%	·	-4.4%	-3.0%	-5.8%	·	-5.3%	-5.3%	-6.2%	·	-4.5%	-6.8%
ROE	-11.0%	·	-6.1%	-10.1%	13.1%	·	-9.4%	-6.6%	-12.4%	·	-11.9%	-11.7%	-13.3%	·	-9.2%	-11.2%
ROIC	-16.5%	·	-7.8%	-11.7%	10.8%	·	-10.4%	-8.1%	-13.7%	·	-16.1%	-16.0%	-17.0%	·	·	·

Liquidità e Solvibilità 4

Dati trimestrali Liquidità e Solvibilità per ARVN
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	5.4	·	5.7	5.6	4.6	·	4.2	3.6	4.9	·	3.3	3.4	4.1	·	5.3	5.8
Quick Ratio	5.3	·	5.6	5.5	4.5	·	4.1	3.5	4.9	·	3.2	3.4	4.0	·	5.2	5.6
Debt / Equity	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0
LT Debt / Equity	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0

Efficienza 2

Dati trimestrali Efficienza per ARVN
Metrica	Tendenza	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover		0.0	·	0.0	0.0	0.2	·	0.1	0.1	0.0	·	0.0	0.0	0.0	·	0.0	0.0
Receivables Turnover		14.2	·	3.0	19.5	944.0	·	8.9	80.5	·	·	4.1	72.7	·	·	21.0	44.7

Per Azione 5

Dati trimestrali Per Azione per ARVN
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$6.00	·	$7.97	$8.32	$9.04	·	$8.53	$8.75	$8.93	·	$8.31	$8.68	$9.57	·	$11.68	$12.61
Revenue / Share	$0.24	·	$0.57	$0.31	$2.60	·	$1.42	$1.06	$0.35	·	$0.64	$1.02	$0.61	·	$0.57	$0.59
Cash Flow / Share	$-1.08	·	·	·	$-1.22	·	·	·	$-1.36	·	·	·	$-1.71	·	·	·
Cash / Share	$1.35	·	$1.43	$1.57	$1.11	·	$1.24	$2.26	$1.29	·	$2.07	$1.70	$2.44	·	$2.49	$1.75
EPS (TTM)	$-1.08	·	$-0.86	$-0.87	$-1.00	·	$-3.32	$-3.89	$-4.94	·	$-5.21	$-5.35	$-5.30	·	$-4.70	$-4.49

Valutazione (TTM) 14

Dati trimestrali Valutazione (TTM) per ARVN
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$269M	·	$356M	$390M	$393M	·	$239M	$191M	$147M	·	$155M	$154M	$126M	·	$103M	$75M
Net Income TTM	$-71M	·	$-63M	$-63M	$-71M	·	$-218M	$-235M	$-282M	·	$-279M	$-285M	$-282M	·	$-246M	$-230M
Market Cap	$684M	·	$603M	$539M	$512M	·	$1.69B	$1.83B	$2.82B	·	$1.08B	$1.33B	$1.46B	·	$2.37B	$2.24B
Enterprise Value	$69M	·	$-184M	$-322M	$-441M	·	$571M	$598M	$1.65B	·	$83M	$288M	$336M	·	$1.10B	$897M
P/E	-9.8	·	-9.9	-8.5	-7.0	·	-7.4	-6.8	-8.4	·	-3.8	-4.6	-5.2	·	-9.5	-9.4
P/S	2.5	·	1.7	1.4	1.3	·	7.1	9.6	19.2	·	7.0	8.6	11.6	·	23.0	29.8
P/B	1.8	·	1.1	0.9	0.8	·	2.9	3.0	4.6	·	2.4	2.9	2.9	·	3.8	3.3
P / Tangible Book	1.8	·	1.1	0.9	0.8	·	2.9	3.0	4.6	·	2.4	2.9	2.9	·	3.8	3.3
P / Cash Flow	-9.9	·	·	·	-5.8	·	·	·	-28.9	·	·	·	-16.0	·	·	·
P / FCF	-9.7	·	·	·	-5.7	·	·	·	-28.9	·	·	·	-15.8	·	·	·
EV / EBITDA	-1.1	·	4.2	4.5	-6.2	·	-9.5	-12.3	-19.8	·	-1.1	-3.9	-3.8	·	-16.3	-13.1
EV / FCF	-1.0	·	·	·	4.9	·	·	·	-16.9	·	·	·	-3.6	·	·	·
EV / Revenue	0.3	·	-0.5	-0.8	-1.1	·	2.4	3.1	11.2	·	0.5	1.9	2.7	·	10.7	11.9
Earnings Yield	-10.2%	·	-10.1%	-11.8%	-14.2%	·	-13.5%	-14.6%	-12.0%	·	-26.5%	-21.6%	-19.4%	·	-10.6%	-10.7%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$263M	$263M	$78M	$131M	$54M
Margine Operativo %	-45.1%	-95.0%	-511.5%	-200.3%	-418.2%
Utile netto	$-81M	$-199M	$-367M	$-282M	$-191M
EPS Diluito	$-1.14	$-2.77	$-6.62	$-5.31	$-3.82

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.0	0.0	0.0	0.0	0.0
Rapporto corrente	4.9	4.6	5.0	4.2	5.9
Quick Ratio	4.8	4.5	4.9	4.1	5.8

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-276M	$-261M	$-351M	$-280M	$555M

Ultime notizie Notizie recenti che menzionano questa società

Rigel Pharma Firma Accordo di Licenza con Arvinas e Pfizer per Veppanu Nasdaq · 1 settimana, 1 giorno fa
Arvinas entra in territorio di ipervenduto (ARVN) Nasdaq · 1 mese, 3 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

ARVN Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

ARVN Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

ARVN Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto tra pari Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi